GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the he...
Das Portfolio von GSK umfasst drei Produktbereiche: Impfstoffe, Spezialmedikamente und Allgemeinmedizin. Unser Ziel ist es, für Patienten weltweit bessere und schnellere Ergebnisse zu erzielen. Unser konkurrenzloses Impfstoffportfolio zielt...
US pharmaceutical industry, serving clients such as Johnson & Johnson, Novartis, and GlaxoSmithKline. In addition, we are working on the...
US pharmaceutical industry, serving clients such as Johnson & Johnson, Novartis, and GlaxoSmithKline. In addition, we are working on the...
US pharmaceutical industry, serving clients such as Johnson & Johnson, Novartis, and GlaxoSmithKline. In addition, we are working on the...